FOR PATHOLOGY
More context from every biopsy.
Today’s workflow turns three-dimensional tissue into a limited set of two-dimensional sections. LIMAA starts digitalization before the slide – and keeps the specimen available for what comes next.
WHERE CONVENTIONAL WORKFLOWS LOSE VALUE
Fragments, handovers and sampling limits.
-
Physical sectioning samples only part of the available tissue.
-
Manual preparation steps add variability, time and scarce hands-on effort.
-
Digitalization begins late, after slide creation and scanning.
-
Tissue can be consumed before molecular questions are fully known.
THE LIMAA ADVANTAGE
One specimen. One continuous data journey.
-
Volumetric inspection of intact tissue architecture.
-
Automated, standardized preparation and imaging.
-
Digital-native output designed for AI-assisted assessment.
-
Preserved tissue optionality for downstream molecular analysis.
ONE ORCHESTRATED WORKFLOW
From sample to decision.
LIMAApath connects proprietary tissue preparation with native 3D light-sheet imaging, AI-assisted analysis and clinical reporting – while remaining open to third-party instruments and lab systems.
01
Register
A traceable start for every specimen.
Connect sample identity, workflow status and downstream data from the first touchpoint.
02
Prepare
Standardize the work before imaging begins.
Proprietary preparation and clearing protocols turn intact tissue into a reproducible, image-ready specimen.
03
Image
Capture native tissue architecture in volume.
Light-sheet microscopy rapidly acquires optical sections through intact tissue – without creating a stack of physical slides.
04
Analyze
Turn spatial context into actionable evidence.
AI-assisted tools help navigate large native datasets, highlight relevant regions and structure diagnostic review.
05
Report
Bring evidence into the clinical workflow.
LIMAApath connects findings, images and workflow status to reporting and downstream clinical decisions.
BEYOND WHOLE-SLIDE IMAGING
A different starting point.
LIMAA is not another scanner layer. The platform changes how tissue becomes digital data – from serial physical sections to direct volumetric acquisition.
Slide-based workflow
TISSUE REPRESENTATION
Selected 2D sections
DIGITAL ENTRY POINT
After slide preparation
SPECIMEN PRESERVATION
Material progressively consumed
AUTOMATION SCOPE
Multiple fragmented systems
DATA FOR AI
Selected planar context
LIMAA native volume
TISSUE REPRESENTATION
Intact 3D tissue volume
DIGITAL ENTRY POINT
Before physical sectioning
SPECIMEN PRESERVATION
Tissue remains intact
AUTOMATION SCOPE
End-to-end orchestration
DATA FOR AI
Volumetric spatial context
CLINICAL FOCUS
A deliberately focused strategy.
We start within familiar pathology workflows –
H&E staining from day one – to demonstrate clinical value first, then expand the platform.
Prostate cancer
First clinical priority.
Gastrointestinal
Followed by gastrointestinal applications.
Advanced assays
Targeted staining technologies such as nanobodies.